• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

New strategic approach to develop therapeutic agent for diabetic retinopathy by regulation of apoptosis of retinal vascular cells and neurons

Research Project

Project/Area Number 14571656
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Ophthalmology
Research InstitutionYamagata University Faculty of Medicine

Principal Investigator

TAKAMURA Hiroshi  Yamagata University Faculty of Medicine, Department of Ophthalmology and Visual Science, Associate Professor, 医学部, 助教授 (10197204)

Co-Investigator(Kenkyū-buntansha) KAWASAKI Ryo  Yamagata University Faculty of Medicine, Department of Ophthalmology and Visual Science, Instructor, 医学部視覚病態学, 助手 (70301067)
YAMASHITA Hidetoshi  Yamagata University Faculty of Medicine, Department of Ophthalmology and Visual Science, Professor, 医学部視覚病態学, 教授 (90158163)
Project Period (FY) 2002 – 2003
Keywordsdiabetic retinopathy / oxidative stress / 8-OHdG / NOx / VEGF / diabetes mellitus(DM) model rats / PKC / DGK
Research Abstract

We investigated the pathophysiological aspects of diabetic retinopathy, focusing on the cellular damage. The apoptosis of retinal cell components (retinal neurons and retinal vascular cells) is caused by various insults including oxidative stress. To evaluate the cell damage by oxidative stress, we observed the expression of 8-hydroxydeoxyguanosine (8-OHdG) and NOx in the eyes with diabetic retinopathy in human eyes. NOx is a marker for NO production, and 8-OHdG is a biological marker of DNA damage due to oxidative stress. 8-OHdG and NOx levels in the human vitreous specimens were measured by ELISA. The vitreous specimens were obtained during the vitreous surgeries from the eyes with proliferative diabetic retinopathy (PDR), branch retinal vein occulusion (BRVO), or macular hole and/or epiretinal membrane (MH/ERM)), after securing the written permission from the subjects. This study has been approved by Ethical Committee of Yamagata University Faculty of Medicine. The mean vitreal conc … More entration of NOx and 8-OHdG in the eyes with PDR was significantly higher than those with BRVO and MH/ERM. The expression of 8-OHdG was observed immunohistochemically in the retinas of the noromal rats and the DM model rats. The expression of 8-OHdG was detected mainly in ganglion cell layer of the STZ rat eyes. Taken together, oxidative damage was more significant in the diabetic eyes than in the BRVO or the MH/ERM eyes. These results suggest that anti-oxidant agents are very good candidates for therapeutic agents for diabetic retinopathy.
We investigated the other approach to develop new therapeutic agents for diabetic retinopathy. In diabetic retinopathy, the production of diacylglycerol (DG) is increased and activates protein kinase C(PKC), which is involved in the signal transduction pathways from various growth factors. Diacylglycerol kinase (DGK) phosphorylates DG, which is degraded into phosphatidic acid (PA), and regulates the intracytoplasmic signal transduction by regulating DG level and inositol-phospholipid turnover. We observed the expression patterns of DGK isoforms and cytokines to investigate the clinical significance of DGK during the pathogenesis of diabetic retinopathy. In the retinal specimens from Streptozotocin induced rats (STZ) and Spontaneously Diabetic Torii (SDT) rats (supplied by the courtesy of Torii Pharmaceutical Co., Ltd., Tokyo, Japan), the expression of DGK isoforms and cytokines (VEGF, IL-6, Angiotensin II, TGF_1,2, and PEDF) was observed immunohistochemically and by Western blotting. The expression patterns and expression levels of DGK, VEGF, IL-6 and angiotensin-II changes in DM model rat retina in comparison with the normal control The expression of DGK and IL-6 was mainly detected in the retinal vessels, and angiotensin-II was observed in the vessels and the inner nuclear layer in the diabetic retina. VEGF expression increased in whole layere of the diabetic retina. It is possible that DGK and VEGF are involved in the pathogenesis in the early stage of DMR, and are good targets to develop new therapeutic agents for diabetic retinopathy. Less

  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] 佐藤さくら, 佐藤浩章, 川崎良, 高村浩, 山下英俊: "眼疾患とRAS"Angiotensin Research (Journal of Angiotensin Research). 1. 73-77 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 川崎良, 高村浩, 山下英俊: "糖尿病網膜症の新しい臨床病期分類と外科治療の現況"医学のあゆみ. 207. 784-789 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 神尾聡美, 川崎良, 高村浩, 山下英俊: "糖尿病網膜症,黄斑症の新しい分類"Diabetes Journal. 31. 1501-1503 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大内典子, 川崎良, 山下英俊: "糖尿病網膜症"Medico. 34. 321-325 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 寺島和人, 高村浩, 山下英俊: "TGF-βと眼疾患"眼科. 45. 31-38 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sato H, Kawasaki R, Yamashita H: "Observation of idiopathic full-thickness macular hole closure in early postoperative period as evaluated by OCT."Am J Ophthalmol. 136. 185-187 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山下英俊, 川崎良, 佐藤浩章, 神尾聡美, 高村浩, 他: "他科から糖尿病専門医に望むもの"糖尿病学の進歩. 第37集. 57-61 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Usui T, Nakajima F, Idta R, Kaji Y, Suzuki Y, Araie M, Miyauchi S, Heldin P, Yamashita H.: "Hyaluronan Synthase (HAS) in Trabecular Meshwork Cells."Br J Ophthalmol. 87. 357-360 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato H, Kawasaki R< Yamashita H.: "Observation of Idiopathic Full-Thickness Macular Hole Closure in Early Postoperative Period as Evaluated by Optical Coherence Tomography."Am J Ophthalmol. 136. 185-187 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tsumamoto Y, Yamashita K, Okada K, Kurokawa T, Yamashita H, Mishima HK.: "Regulation of BDNF and its receptor TrkB in retina of normal aged mice and senescence-accelerated mice."Invest Ophthalmol Vis Sci (74th ARVO 2002.5.5-9). 43. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamane K, Minamoto A, Mishima HK, Yamashita H, Takamura H, Yoshizato K: "Proteome analysis of normal human vitreous fluid"Invest Ophthalmol Vis Sci(74th ARVO 2002.5.5-9). 43. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kawasaki R, Kamiryo M, Sato H, Sato T, Saito T, Tominaga M, Kato T, Yamashita H: "The prevalence of diabetic retinopathy and other fundus disease in Japanese population"Invest Ophthalmol Vis Sci(74th ARVO 2002.5.5-9). 43. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sakura S, Katagiri Y, Goto K, Yamashita H: "Expression patterns of diacylglycerol kinase (DGK) isozymes in normal rat retina"Invest Ophthalmol Vis Sci(74th ARVO 2002.5.5-9). 43. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.Sato, Y.Katagiri, K.Goto, M.Igarashi, H.Yamashita: "Immunohistochemical Observation of Diacylglycerol Kinase (DGK) in Normal and the Early Stage of Diabetic Rat."Invest Ophthalmol Vis Sci(75th ARVO 2003.5.4-8). 44. (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Sato, R.Kawasaki, T.Yamamoto, T.Yamashita, H.Yamashita: "Evaluation of Cell Damage by Measuring Vitreous Level of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in Retinal Diseases."Invest Ophthalmol Vis Sci(75th ARVO 2003.5.4-8). 44. (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi